Trichomonas vaginalis
Protective Immunity to T. vaginalis in a Mouse Model of Vaginal Infection
Published in Women's Health Weekly, September 30th, 1996
According to an abstract submitted by the authors to the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in New Orleans, Louisiana, September 15-18, 1996, "Trichomonas vaginalis [TV] is the most frequently encountered sexually transmitted disease worldwide with impact on women by causing severe vaginitis, premature rupture of membranes and increases the risk of HIV acquisition. We studied the protective effect of subcutaneous immunization with T. vaginalis using a well characterized mouse model of vaginal infection. Balb/c mice were immunized with doses of T. vaginalis (4.5x105, 9x106, 1x108)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer (Screening)
Beauty Salon-Based Outreach Program is a National Model - Breast Cancer (Screening)
Absorbent Disks: New Method of Screening for Breast Cancer - Breast Cancer (Diagnostics)
11-Gauge Probe and Micromark Clip Introduced - Breast Cancer (Mortality)
Texas Study Looks at Survival Rates in African-Americans - Breast Implants (Legal Issues)
Breast Implant Suit In Texas Lost by Plaintiffs - Conference Coverage (ICAAC)
Group B Strep Vaccine Developed, Will It Be Used? - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
